Simulations Plus Named to Fortune Small Business FSB 100 List

* Reuters is not responsible for the content in this press release.

Tue Jul 7, 2009 9:25am EDT

LANCASTER, Calif.--(Business Wire)--
Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of simulation and
modeling software for pharmaceutical discovery and development, has been named
to the ninth annual Fortune Small Business FSB 100 list of the fastest-growing
small public companies in America. 

Ms. Renee Bouche, Investor Relations Manager for Simulations Plus, noted: "The
July/August issue of Fortune Small Business has just released its annual list of
the 100 fastest-growing small public companies in America, and Simulations Plus
is privileged to be making its first appearance. The list, comprised of
U.S.-domiciled firms with annual revenues below $200 million and a stock price
above $1, is based on revenue growth and stock performance over the past three
years plus a new requirement this year of no negative growth in any of the most
recent four quarters. In describing the accomplishments of the FSB 100, Fortune
Small Business writes, `...in this Great Recession, their performance is nothing
short of miraculous...All 100 companies on our list have figured out how to
succeed no matter what the economic climate.` Simulations Plus was ranked 53rd."


Walt Woltosz, chairman and chief executive officer of Simulations Plus, added,
"This was unexpected and a pleasant surprise to be included in this prestigious
list." 

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery
and development simulation software, which is licensed to and used in the
conduct of drug research by major pharmaceutical and biotechnology companies
worldwide. We have two other businesses that are based on our proprietary
technologies: a wholly owned subsidiary, Words+, Inc., which provides assistive
technologies to persons with disabilities; and an educational software series
for science students in middle and high schools known as FutureLab™. For more
information, visit our Web site at www.simulations-plus.com. 





Investor Relations
Simulations Plus, Inc.
Ms. Renée Bouché, 661-723-7723
info@simulations-plus.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.